Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
private:mitrabiotech | 1336485 | May 30th, 2019 12:00AM | Mitra Biotech | 5.4K | 138.00 | Open | Biotechnology | May 29th, 2019 08:46PM | May 29th, 2019 08:46PM | Mitra Biotech is a global leader in advancing personalized cancer treatment. We are evolving the personalization of treatment selection and drug development through our phenotypic platforms that reliably predict individual response to tested treatment. Founded in 2010, Mitra is headquartered in Woburn, MA and maintains a significant research and laboratory presence in Bangalore, India. We are committed to developing new technologies that surpass existing biomarker-guided strategies for cancer treatment selection, expanding access to truly personalized medicine, and enhancing the clinical management of cancer. Our unique CANscript™ platform delivers individualized treatment response predictions to inform patient-specific cancer treatment selection and enhance drug discovery and development. Mitra partners with leading hospitals and pharmaceutical companies worldwide. | Open | Biotechnology, Cancer research, Personalized cancer care, Translational biology | Open | Woburn | MA | US | 01801 | Mitra Biotech | Pharmaceuticals & Biotechnology | |||
private:mitrabiotech | 1336485 | Nov 7th, 2017 12:00AM | Mitra Biotech, Inc. | 2.5K | 86.00 | Open | Biotechnology | Nov 7th, 2017 06:17PM | Nov 7th, 2017 06:17PM | Mitra Biotech is a global leader in advancing personalized cancer treatment. We are evolving the personalization of treatment selection and drug development through our phenotypic platforms that reliably predict individual response to tested treatment. Founded in 2010, Mitra is headquartered in Woburn, MA and maintains a significant research and laboratory presence in Bangalore, India. We are committed to developing new technologies that surpass existing biomarker-guided strategies for cancer treatment selection, expanding access to truly personalized medicine, and enhancing the clinical management of cancer. Our unique CANscript™ platform delivers powerful, individualized treatment response predictions — with exceptionally high correlation to clinical outcomes — to inform patient-specific cancer treatment selection and enhance drug discovery and development. The CANscript platform has been validated using thousands of cancer patients. Mitra partners with leading hospitals and pharmaceutical companies worldwide. | Mitra Biotech | Pharmaceuticals & Biotechnology | ||||||||||
private:mitrabiotech | 1336485 | Nov 1st, 2017 12:00AM | Mitra Biotech, Inc. | 2.5K | 85.00 | Open | Biotechnology | Nov 1st, 2017 05:56AM | Nov 1st, 2017 05:56AM | Mitra Biotech is a global leader in advancing personalized cancer treatment. We are evolving the personalization of treatment selection and drug development through our phenotypic platforms that reliably predict individual response to tested treatment. Founded in 2010, Mitra is headquartered in Woburn, MA and maintains a significant research and laboratory presence in Bangalore, India. We are committed to developing new technologies that surpass existing biomarker-guided strategies for cancer treatment selection, expanding access to truly personalized medicine, and enhancing the clinical management of cancer. Our unique CANscript™ platform delivers powerful, individualized treatment response predictions — with exceptionally high correlation to clinical outcomes — to inform patient-specific cancer treatment selection and enhance drug discovery and development. The CANscript platform has been validated using thousands of cancer patients. Mitra partners with leading hospitals and pharmaceutical companies worldwide. | Mitra Biotech | Pharmaceuticals & Biotechnology |